... and B non- small- celllungcancer J Clin Oncol 2005, 23:3760-3767 El Sharouni SY, Kal HB, Battermann JJ: Accelerated regrowth of non- small- celllung tumours afterinduction chemotherapy Br J Cancer ... Docetaxel and concurrent radiotherapy after two cycles ofinduction chemotherapy with cisplatin and vinorelbine in patientswith locally advanced non- small- celllungcancer A phase II trial conducted ... Concurrent chemoradiotherapy in non- smallcelllungcancer (Review) In The Cochrane Library Volume Wiley; 2005:1-37 Vokes EE: Optimal therapyfor unresectable stage III nonsmall -cell lungcancer J Clin...
... included mixed groups ofpatientswith primary small or non- smallcelllungcancer (NSCLC) and lung metastases, and did not compare VOC levels in lungcancerpatientswith those in asymptomatic smokers ... Ib and IIa lungcancer None of the patients received radiation or chemotherapy before surgery The study also included 25 subjects with clinically stable, mild to moderate COPD, all of whom were ... 82.5% of subjects were correctly classified: a maximum of 87.8% for control non- smokers and a minimum of 72.2% for the NSCLC patients Analysis of residuals did not reveal any particular cases with...
... radiation therapyfor Page of (page number not for citation purposes) Radiation Oncology 2006, 1:30 22 23 24 http://www.ro-journal.com/content/1/1/30 inoperable non- smallcelllungcancer without mediastinal ... treatments oflung tumors have recently been published [5,6] This paper reports on outcomes in 58 patientswith metastases in the lungs or with histologically confirmed, small, peripheral, non- small- cell ... Mitsuhashi N, Saito Y, et al.: Limited field irradiation for medically inoperable patientswith peripheral stage I non- smallcelllungcancerLungCancer 1999, 26:137-142 Slotman BJ, Antonisse IE, Njo...
... pulmonary fibrosis associated withinduction chemotherapy with carboplatin and vinorelbine followed by CHART radiotherapy for locally advanced nonsmall celllungcancer Clin Oncol 2002, 14:361-366 ... R: Analysis of clinical and dosimetric factors associated with treatmentrelated pneumonitis (TRP) in patientswith non- small- celllungcancer (NSCLC) treated with concurrent chemotherapy and ... factors associated with severe acute radiation pneumonitis in patientswith locally advanced non- smallcelllungcancer treated with concurrent chemotherapy and intensity-modulated radiotherapy Radiation...
... R, Stewart DJ, Karp DD: Number of Metastatic Sites is a Strong Predictor of Survival in Patientswith Nonsmall CellLungCancerWith or Without Brain Metastases Cancer 2009, 115:2930-2938 doi:10.1186/1748-717X-6-80 ... non- small- cell- lungcancer treated with definitive radiation therapy: impact of tumor volume IJROBP 2006, 64:449-454 30 Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N: Effect of ... Nakagawa A, Tsubota N: Effect of Tumor Size on Prognosis in PatientswithNonSmallCellLung Cancer: the Role of Segmentectomy as a Type of Lesser Resection J Thoracic Cardiovasc Surg 2005, 129:87-93...
... escalation in non- small- celllungcancer Int J Radiat Oncol Biol Phys 2001, 49:23-33 Abratt RP, Bogart JA, Hunter A: Hypofractionated radiation for non- smallcelllungcancerLungCancer 2002, ... Background Materials and methods The use of accelerated hypofractionated radiation therapy is an attractive option forpatientswith early stage nonsmall celllungcancer (NSCLC) who are not surgical ... I non- smallcelllungcancer Int J Radiat Oncon Biol Phys 2002, 52:1047-57 Qiao X, Tullgren O, Lax I, Sirzen F, Lewensohn R: The role of radiation therapy in treatment of stage I non- small cell...
... Committee ofLungCancer Registry Prognosis of 6644 resected non- smallcelllung cancers in Japan: a Japanese lungcancer registry study LungCancer 2005, 50:227-34 11 Andre F, Grunenwald D, Pignon ... trends of surgical outcome in patientswith non- smallcelllungcancer J Thorac Oncol 2010, 5:825-9 Ou SH, Zell JA: Validation study of the proposed IASLC staging revisions of the T4 and M non- small ... effectiveness ofinduction chemotherapy [20] Most studies report that surgical resection is recommended only forpatientswithmediastinal downstaging after chemotherapy, and not all patientswith persistent...
... unfit older patientswith advanced NSCLC Cancer Treatment Reviews 2009, 35:517-521 Gérard C, Debruyne C: Immunotherapy in the landscape of new targeted treatments for non- smallcelllungcancer Mol ... as first-line treatment forpatientswith advanced non- small- celllungcancerwith activating epidermal growth factor receptor mutation: Review of the evidence LungCancer 2011, 71(3):249-57 Pirker ... preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced nonsmallcelllungcancer (NSCLC) patients Journal of Immune Based Therapies...
... Randomized study of paclitaxelcisplatin versus cisplatin-teniposide in patientswith advanced non- small- celllungcancer The European Organization for Research and Treatment ofCancerLungCancer Cooperative ... Fairclough D, Cella D, Cella D, Kugler J, Rowinsky E, Jiroutek M, Johnson D: Comparison of survival and quality of life in advanced non- small- celllungcancerpatients treated with two dose levels of paclitaxel ... pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patientswith inoperable non- smallcelllungcancerLungCancer 2001, 33:277-287 Publish with Bio Med Central and every...
... M: Non- small- celllungcancer harbouring mutations in the EGFR kinase domain Clin Transl Oncol 2010, 12:75-80 Gazdar AF: Activating and resistance mutations of EGFR in non- small- celllung cancer: ... A, et al: EGFR mutations in nonsmall -cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications ... chain reaction for the detection of mutations and deletions in the epidermal growth factor receptor gene: applications of this method for the diagnosis of non- small- celllungcancer Clin Chim...
... radiotherapy of non- small- celllungcancer Int J Radiat Oncol Biol Phys 2002, 52:382-389 Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapy in treatment of stage I non- small ... Hara R, Itami J, Yamada K, Araki T: Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non- smallcelllung cancer: updated results of 257 patients in a Japanese multi-institutional ... 18 19 20 21 22 a prospective phase II trial of medically inoperable stage I non- small- celllungcancerpatients treated with stereotactic body radiotherapy J Clin Oncol 2009, 27:3290-3296 Takeda...
... Hara R, Itami J, Yamada K, Araki T: Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non- smallcelllung cancer: updated results of 257 patients in a Japanese multi-institutional ... stereotactic body radiotherapy for stage I non- smallcelllungcancer Radiother Oncol 2007, 85:429-434 Sinha B, McGarry RC: Stereotactic body radiotherapy for bilateral primary lung cancers: the Indiana ... review of nonsurgical treatment options for stage I non- smallcelllungcancer Oncologist 2008, 13:309-319 Brock J, Ashley S, Bedford J, Nioutsikou E, Partridge M, Brada M: Review of Hypofractionated...
... cause of death among the patients was DM and the overall rate of DM was 36% Of the 31 patientswith local regional failure, 26 (22% ofpatients overall) had IFF The other patients (4.3% of all patients) ... Concannon JP, Rotman M: Impact of irradiation technique and tumor extent in tumor control and survival ofpatientswith unresectable non- oat cell carcinoma of the lung: report by the Radiation Therapy ... irradiation be omittd in Stage III non- smallcelllung cancer? An analysis of recurrences in a phase II study ofinduction chemotherapy and involved-field radiotherapy Int J Radiat Oncol Biol Phys...
... Kirsch CM: Comparison of different methods for delineation of 18F-FDG PET- positive tissue for target volume definition in radiotherapy ofpatientswith non- Smallcelllungcancer J Nucl Med 2005, ... during radiotherapy forpatientswith stage III non- small- celllungcancer Int J Radiat Oncol Biol Phys 2008, 71:139-144 Siker ML, Tome WA, Mehta MP: Tumor volume changes on serial imaging with megavoltage ... Jin JY, Mutic S, El Naqa I, Siegel BA, Bradley JD: 18F-FDG PET definition of gross tumor volume for radiotherapy of non- smallcelllung cancer: is a single standardized uptake value threshold approach...
... appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) forlung cancers: are patientswith pulmonary emphysema also candidates for SBRT forlung ... McGarry RC: FDG -PET and stereotactic body radiotherapy (SBRT) for stage I non- small- celllungcancerLungCancer 2007, 56:229-234 Ballonoff A, Kavanagh B, Schefter T: The effect of novel molecularly ... Hulten U: Stereotactic hypofractionated radiotherapy for stage I non- smallcelllungcancer – mature results for medically inoperable patientsLungCancer 2006, 51:97-103 Anantham D, Feller-Kopman...
... stabilization of PEM in 37.5% of the patients treated with antineoplastic therapy (with or without immunotherapy) in 20.6% ofpatients treated with immunotherapy and in 11.6% of untreated patients ... cause of seizures in patientswithlungcancer New onset of paraneoplastic limbic encephalitis in patientswith already diagnosed lungcancer is usually associated with progression or relapse of ... Paraneoplastic syndromes occur in 10–20% ofpatientswithlungcancerSmallcelllungcancer (SCLC) is associated with the greatest frequency and diversity of paraneoplastic syndromes, including Cushing's...
... Vaccines and Therapy 2005, 3:5 Background Lungcancer is a leading cause ofcancer death in Australia and the world [1,2] There are two types oflung cancers, nonsmallcell (NSCLC) and smallcell (SCLC) ... time of transfection Lipofectamine 2000 was diluted in serum-free DMEM and mixed with dsRNA at a 1:2 ratio (4 µl of 20 µmol/L of siRNA formulated with µl of Lipofectamine 2000) The formulation of ... non- smallcelllungcancer BMJ 2002, 325:452-453 Cridelli C: Targeted therapies in the treatment ofnonsmallcelllung cancer: Curr Opin Oncol 2004, 26:126-129 Evans TL, Lynch TJ Jr: Lung Cancer...
... outcomes in patients treated with adjuvant chemotherapy after complete resection of non- smallcelllung carcinoma Cancer Res 2010, 70:8288-98 Goldstraw P: The 7th Edition of TNM in Lung Cancer: what ... marker expression in tumor cells versus stromal cells in nonsmallcelllungcancer Clin Cancer Res 2007, 13:6649-57 World Health Organization: Histological Typing ofLung and Pleural Tumours Geneva, ... RM, Busund LT: Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cells and stromal compartment in non- smallcelllungcancer Anticancer Res 2009, 29:4175-83 Al-Saad S,...
... JR, Peterson MW: Staging ofsmallcell and non- smallcelllungcancer University of Iowa Virtual Hospital; 1999 Hopwood P, Stephens RJ: Symptoms at presentation for treatment in patientswithlung ... Treatment ofCancer Quality -of- Life Questionnaire -Lung Cancer- 17 items; EQ-5D: EuroQoL-5 Dimensions; HRQL: Healthrelated Quality of Life; NSCLC: Non- SmallCellLung Cancer; SF-36: Short-Form 36 ... RJ, Waller D, West P, Peake MD: Assessment of Quality of Life in the Supportive Care setting of the Big Lung Trial in Non- Small- CellLungcancer Journal of Clinical Oncology 2005, 30:7417-7427 Silvestri...